COMPANY
GLENMARK PHARMACEUTICALS EUROPE LIMITED
GLENMARK PHARMACEUTICALS EUROPE LIMITED: marketing authorisation holder for Desmopressin, Icatibant, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Desmopressin | DESMOPRESSIN ACETATE 100 MICROGRAM TABLETS, PLGB 25258/0376, Authorised Regulator MHRA |
|---|---|
| Desmopressin | DESMOPRESSIN ACETATE 200 MICROGRAM TABLETS, PLGB 25258/0377, Authorised Regulator MHRA |
| Icatibant | ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 25258/0352, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.